2023-12-19 | Company
Company report 2022
During 2022, we initiated the expansion of the R&D capacity at our US site in Putnam and increased our capabilities with a new line for aseptic fill and finish. Read the full company report.
2023-12-19 | Company
During 2022, we initiated the expansion of the R&D capacity at our US site in Putnam and increased our capabilities with a new line for aseptic fill and finish. Read the full company report.
2022-10-13 | Company
Our goal is to build a global CDMO with a niche strategy. There are few high-potency product manufacturers, and almost no one works with polymer implants. Read the full company report.
2022-08-03 | Company
Jessica Jonasson is our new Global HR Director. Jessica enters a global role that will encompass activities at all Sever Pharma Solutions sites, involving all human resources aspects of the CDMO group.